Afstyla (recombinant)

Common Brands Actos
Drug Class
Thiazolidinedione
Controlled Substance Classification
Not a controlled medication
Generic Status
Lower-cost generic available
Availability
Prescription only
Allison Barnes, PharmD
Allison Barnes, PharmD
Read More
Medically reviewed by Allison Barnes, PharmD last update on 20/12/2023

Overview

Afstyla (recombinant) is a medication used to treat hemophilia A, a rare genetic bleeding disorder that impairs the body’s ability to form blood clots. This therapeutic protein is designed to replace the missing or deficient clotting factor VIII in patients with hemophilia A. By providing the essential factor VIII, Afstyla helps individuals with this condition effectively manage and prevent bleeding episodes, allowing them to lead more normal lives.

DRUG STATUS

Availability

Prescription only

Pregnancy & Lactation

Pregnancy